Fink Eric 4
4 · Global Blood Therapeutics, Inc. · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Fink Eric
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-01+3,020→ 3,342 total - Exercise/Conversion
Restricted Stock Units
2021-02-01−3,020→ 18,120 total→ Common Stock (3,020 underlying) - Tax Payment
Common Stock
2021-02-01$49.49/sh−947$46,867→ 2,395 total - Award
Common Stock
2021-02-01$42.60/sh+322$13,717→ 322 total
Footnotes (4)
- [F1]Shares acquired pursuant to the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]Represents number of shares of Issuer's Common Stock sold to satisfy the Reporting Person's tax obligations in connection with the vesting of 3,020 shares of Common Stock underlying the Reporting Person's RSUs.
- [F4]The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.